The hidden role of gold nanoparticles in Southeast Asian diagnostics

Gold nanoparticles’ contribution depends on precise control of the particles themselves and on the other components around them.

Rapid diagnostic tests are used across a range of healthcare applications, including the detection of infectious diseases. Across Southeast Asia, immunochromatographic test technologies are applied to respiratory infections such as influenza and COVID-19, as well as mosquito-borne diseases including dengue, chikungunya, and Zika.

These applications have particular relevance in the region, where both respiratory and mosquito-borne infectious diseases present ongoing healthcare challenges.

Although the diseases and specimens being tested may differ, the basic challenge is similar: recognising a target and making the result visible in a practical test format.

A rapid test may appear simple to use, but the result depends on a series of interactions between the biological components and materials inside the test. Gold nanoparticles are widely used as highly effective labels in immunochromatographic tests, helping make the reaction clearly visible.

Inside the rapid diagnostic test
Immunochromatography uses the movement of a sample through a test membrane together with the interaction between an antigen and an antibody.

Assays can be designed to detect either antigens or antibodies. Antigen tests identify components of a pathogen, such as viral proteins, using antibodies that bind specifically to the target. Antibody tests instead detect the antibodies produced by the body's immune response.

In both cases, biological recognition is translated into a visible signal on the test strip. When a viral antigen is present in a specimen, it reacts with colloidal-gold-labelled antibodies to form complexes. These complexes move through the membrane by capillary action and bind to capture antibodies immobilised in the detection area. The gold nanoparticles used as the label produce a coloured band, allowing the reaction to be seen.

Gold nanoparticles are particularly well suited to this role because of their distinctive optical and surface properties. Their localised surface plasmon resonance produces a strong visible colour, allowing accumulated particles to be detected by the naked eye without complex instrumentation. They are also chemically stable and can readily be conjugated with biomolecules such as antibodies, making them highly practical labels for rapid diagnostic applications.

Producing high-quality gold nanoparticles is itself an important part of diagnostic performance. Particle size, shape, dispersion and batch-to-batch consistency can affect their optical properties and stability, and ultimately the reproducibility of a test. Achieving tightly controlled and consistent nanoparticle characteristics therefore requires specialised synthesis and manufacturing expertise.

The nanoparticles are only one part of the system. Protein immobilisation, suppression of nonspecific adsorption, and enhancement of antigen-antibody reactions all contribute to how an immunochromatographic reagent ultimately performs.

From detection reaction to finished test
The materials science is only part of what determines whether a rapid test performs consistently in the field. Producing a complete diagnostic test product involves several steps that each carry their own quality requirements.

These can include the development and manufacturing of the test strip and the extraction buffer, followed by packaging with components such as filters and swabs. Buffer formulation influences how a specimen is released and presented to the reagent, whilst the physical components affect how consistently a sample is collected.

Because these steps interact, variation at one stage can affect the final result even when the detection chemistry is sound. Integrating development and manufacturing within a single quality framework, built around a recognised medical-device standard such as ISO 13485, is one way the industry maintains lot-to-lot consistency and stable supply.

For healthcare providers and laboratories across Asia, this is the practical significance of the manufacturing layer: reproducibility and continuity of supply during periods of high demand depend as much on process control as on the science of detection.

Different targets, the same basic principle
Immunochromatographic technology can be applied to a range of diagnostic targets. Examples include respiratory infections such as influenza, adenovirus, respiratory syncytial virus, and COVID-19, as well as mosquito-borne infectious diseases including dengue, chikungunya, and Zika. Depending on the test, specimens can include saliva, blood, and urine. Pregnancy testing is another application.

Dengue provides a particularly relevant example for Southeast Asia. Transmitted primarily by Aedes mosquitoes, dengue remains an important infectious-disease challenge across the region. In Thailand, for example, hundreds of suspected dengue cases continued to be reported each week during August 2026, highlighting the continuing importance of diagnostic capabilities in the region.

Dengue is one of several diseases, alongside respiratory infections, where rapid in vitro testing is already in routine use. All build on the same principle: biological recognition of a target combined with materials such as colloidal gold to generate a visible result.

Advanced technology behind a simple result
For the person using a rapid diagnostic test, the result may be as simple as the appearance of a line. Behind that simple result, however, is the integration of biological recognition, advanced materials and precisely controlled manufacturing processes.

Gold nanoparticles are central to that system, but their contribution depends on precise control of the particles themselves and on how well they interact with the antibodies, proteins, and other components around them.

Reliable rapid diagnostics therefore require more than an effective detection reaction. From gold nanoparticle control and immunochromatographic technology to extraction-buffer formulation, test-kit development, and quality-controlled manufacturing, each element contributes to the performance and consistency of the final product.

As Southeast Asia continues to manage both endemic mosquito-borne diseases and recurring respiratory infections, the reliability of these tests will rest on how well materials science, diagnostic development and manufacturing discipline are brought together behind a result that looks, to the user, like nothing more than a coloured line.